Processes and intermediates for making sweet taste enhancers
US-2016289200-A1 · Oct 6, 2016 · US
US9687015B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9687015-B2 |
| Application number | US-201615224421-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2016 |
| Priority date | Aug 6, 2012 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention includes compounds having structural formula (Ia): or salts or solvates thereof. These compounds are useful as sweet flavor modifiers. The present invention also includes compositions comprising the present compounds and methods of modulating the sweet taste of compositions.
Opening claim text (preview).
What is claimed is: 1. An ingestible composition comprising a compound having structural Formula (Ia): or a salt or solvate thereof; wherein m is 4, and n is 0; or m is 3, and n is 1; or m and n are both 2; q is 0, 1, 2, or 3; X is a covalent bond; Y is alkyl, substituted alkyl, carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl; and each R 2 is independently selected from the group consisting of alkyl, halo, hydroxyl, alkoxy, and haloalkyl, wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, ═O, —OR b , —SR b , ═S, —NR c R c , ═NR b , ═N—OR b , trihalomethyl, —CF 3 , —CN, —OCN, —SCN, —NO, —NO 2 , ═N 2 , —N 3 , —S(O) 2 R b , —S(O) 2 OR b , —OS(O) 2 R b , —OS(O) 2 OR b , —P(O)(OR b )(OR b ), —C(O)R b , —C(S)R b , —C(NR b )R b , —C(O)OR b , —C(S)OR b , —C(O)NR c R c , —C(NR b )NR c R c , —OC(O)R b , —OC(S)R b , —OC(O)OR b , —OC(S)OR b , —NR b C(O)R b , —NR b C(S)R b , —NR b C(O)OR b , —NR b C(S)OR b , —NR b C(O)NR c R c , —NR b C(NR b )R b and —NR b C(NR b )NR c R c , where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each R b is independently hydrogen or R a ; and each R c is independently R b or alternatively, the two R c s may be taken together with the nitrogen atom to which they are bonded form a 4-, 5-, 6- or 7-membered cycloheteroalkyl which may optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O (oxygen), N (nitrogen) and S (sulfur); and an ingestibly acceptable excipient. 2. The ingestible composition of claim 1 , wherein the compound is represented by structural Formula (Ib): or a salt or solvate thereof; wherein, Y is alkyl, substituted alkyl, carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl. 3. The ingestible composition of claim 1 , wherein the compound is represented by structural Formula (Id): or a salt or solvate thereof; wherein, Y is alkyl, substituted alkyl, carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl. 4. The ingestible composition of claim 1 , wherein the compound is selected from the group consisting of or a salt or solvate thereof. 5. The ingestible composition of claim 4 , wherein the compound is selected from the group consisting of or a salt or solvate thereof. 6. The ingestible composition of claim 1 , wherein the compound is selected from the group consisting of or a salt or solvate thereof. 7. The ingestible composition of claim 1 , wherein the compound is selected from the group consisting of or a salt or solvate thereof. 8. An ingestible composition comprising a compound having structural Formula (Ia): or a salt or solvate thereof; wherein m is 4, and n is 0; or m is 3, and n is 1; or m and n are both 2; q is 0, 1, 2, or 3; X is a covalent bond or —NR 1 —; R 1 is hydrogen or C1 to C6 alkyl; Y is carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl; and each R 2 is independently selected from the group consisting of alkyl, halo, hydroxyl, alkoxy, and haloalkyl, wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, ═O, —OR b , —SR b , ═S, —NR c R c , ═NR b , ═N—OR b , trihalomethyl, —CF 3 , —CN, —OCN, —SCN, —NO, —NO 2 , ═N 2 , —N 3 , —S(O) 2 R b , —S(O) 2 OR b , —OS(O) 2 R b , —OS(O) 2 OR b , —P(O)(OR b )(OR b ), —C(O)R b , —C(S)R b , —C(NR b )R b , —C(O)OR b , —C(S)OR b , —C(O)NR c R c , —C(NR b )NR c R c , —OC(O)R b , —OC(S)R b , —OC(O)OR b , —OC(S)OR b , —NR b C(O)R b , —NR b C(S)R b , —NR b C(O)OR b , —NR b C(S)OR b , —NR b C(O)NR c R c , —NR b C(NR b )R b and —NR b C(NR b )NR c R c , where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each R b is independently hydrogen or R a ; and each R c is independently R b or alternatively, the two R c s may be taken together with the nitrogen atom to which they are bonded form a 4-, 5-, 6- or 7-membered cycloheteroalkyl which may optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O (oxygen), N (nitrogen) and S (sulfur); and an ingestibly acceptable excipient. 9. The ingestible composition of claim 8 , wherein X is NH. 10. The ingestible composition of claim 8 , wherein X is a covalent bond. 11. The ingestible composition of claim 8 , wherein the compound is represented by structural Formula (Ib): or a salt or solvate thereof; wherein, Y is carbocyclyl,
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches · CPC title
Taste or flavour enhancing agents · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.